The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes

Clinical trial NCT06000462 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06000462
Sponsor: Oman Ministry of Health
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Obesity Dapagliflozin Adverse Reaction Weight Loss Effect of Drug

Start date: 2024-04-22
Primary completion: 2025-08-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.